Panel Discussion: How Is Translational Proteomics Shaping the Future of Drug Target Discovery?
-
How is proteomics helping researchers move beyond genomics to identify more actionable drug targets, particularly in complex or poorly understood diseases?
-
What are some recent breakthroughs or case studies where proteomics has directly influenced the discovery or validation of a novel drug target?
-
How are advances in mass spectrometry, single-cell proteomics, or spatial proteomics enhancing our ability to identify meaningful targets?
-
What are the biggest challenges in integrating proteomics with other omics data (e.g. transcriptomics, metabolomics) and how are organizations overcoming them in drug discovery pipelines?